Inovio (INO) Stock: Here’s What You Need To Know

Inovio Pharmaceuticals (NASDAQ:INO) On Monday, Inovio Pharmaceuticals closed the day down by 17% after the company announced that the FDA had placed its trial initiation on hold. This refers to the phase 3 clinical trial that was supposed to begin shortly treating women with cervical dysplasia or CIN 2/3 lesions. The vaccine to be used … Read more

Biotech Stock News (INO) (NYMX)

Inovio Pharmaceuticals (NASDAQ:INO) On Monday June 20, 2016 Inovio Pharmaceuticals along with one of its subsidiaries Gene One Life Sciences have received authorization from the FDA to begin a first ever trial in humans targeting the Zika Virus. This is a monumental event, because it will the first trial ever to begin treating humans with … Read more

Biotech Stock News (INO) (INCY) (NVS)

Inovio Pharmaceuticals (NASDAQ:INO) On Thursday January 28, 2016 shares of Inovio closed the day up approximately 8% after the company announced it would start to recruit for a MERS vaccine trial. MERS stands for Middle Eastern Respiratory Syndrome. This trial is being collaborated between Inovio and Gene One Life Sciences. MERS is a respiratory illness … Read more

Biotech Stock News (INO) (TTPH) (AKBA)

Inovio Pharmaceuticals (NASDAQ:INO)¬† On September 8, 2015 Inovio announced that it had dosed its first patient with its Universal HIV vaccine known as PennVax-GP. This trial is being run as a phase 1 trial that will assess the safety and tolerability of the vaccine in these patients with HIV. Although the phase 1 trial primarily … Read more

Biotech Stock News (INO) (AZN) (IMUC) (AAVL) (REGN)

Inovio Pharmaceuticals (NASDAQ:INO) On August 10, 2015 shares of Inovio were up about 25% after the company announced a partnership deal with a big pharmaceutical company known as AstraZeneca (NYSE:AZN).¬†Although one key thing to note here is that this deal is being established with MedImmune specifically, but it is the research and development arm for … Read more

Inovio Pharmaceuticals (INO) Posts Wider Than Expected Losses

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals stock is straddling the previous closed; confused as to where to go following the earnings report. Today, we’ll discuss what we saw from earnings, how the market reacted to the news, and what we can expect to see moving forward. So, let’s get right to it… Inovio Pharmaceuticals … Read more

Inovio Pharmaceuticals (INO) Stock | Can The Recovery Continue?

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals stock fell in a big way yesterday; and in all honesty, it happened for good reason. The company announced the details of a secondary offer that would send 9,500,000 more shares into the public world. As a result, investors became concerned about dilution and a sell off ensued. … Read more

Inovio Pharmaceuticals (INO) Stock Is Down | Dilution Is A Big Concern

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals stock is down today; and in a big way. The reason is clear to see; investors are concerned about share dilution. The truth is, they have every right to be. Nonetheless, I think the downtrends are presenting a great buying opportunity. Below, we’ll chat about why share dilution … Read more

Biotech Stock News (RGLS)(AZN)(INO)(TKMR)

Regulus Therapeutics (NASDAQ:RGLS) & AstraZeneca (NYSE:AZN)¬† On April 7, 2015 Shares of Regulus were up about 8% in after hours trading after the company reported that Astrazeneca would like to collaborate with the company to develop a NASH drug. NASH stands for non-alcoholic steatohepatitis and as the name suggests it is a disease that doesn’t … Read more

Inovio Pharmaceuticals (INO) Climbs On HPV Treatment

Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals stock spiked this morning due to new data revolving around a new treatment they’ve been working on. The treatment is designed to treat patients suffering from HPV and has shown some pretty impressive results. Today, we’ll talk about the results INO announced early today, how the company’s stock … Read more